Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
scRNA seq data of cellular infiltrates of CT2A tumor-bearing mice
应用场景：
创建时间：
2023-10-18
相关数据集
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages I
The interplay between glioblastoma stem cells (GSCs) and tumor-associated macrophages (TAMs) promotes progression of glioblastoma multiforme (GBM). However, the detailed molecular mechanisms underlyin
NIAID Data Ecosystem80
Tumor-derived Schwann-like cells promote neuroblastoma survival through secreted trophic factors. Tumor-derived Schwann-like cells promote neuroblastoma survival through secreted trophic factors
Neuroblastoma (NB) is comprised of a mixture of neuroblastic N-type cancer cells, and Schwannian stromal S-type cells. Sublines of N- and S-type cells were isolated from an early passage of SK-N-SH NB
NIAID Data Ecosystem40
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression. Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression
Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis and high recurrence rates. The complex immune microenvironment of GBM is highly infiltrated by tumor-associated microglia and
NIAID Data Ecosystem30
Table_1_Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues.xlsx
Laser capture microdissection (LCM) coupled with RNA-seq is a powerful tool to identify genes that are differentially expressed in specific histological tumor subtypes. To better understand the role o
NIAID Data Ecosystem60
Tumor and microenvironment reprogramming during radiochemotherapy in glioma using a combined diagnostic imaging and single-cell RNA sequencing approach
Glioblastoma (GBM) is the most common primary brain tumor in adults with a median survival of 11-12 months. Standard therapy consists of radiotherapy (RT) plus chemotherapy with Temozolomide (TMZ), an
NIAID Data Ecosystem40
